08. March 2022

Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001)

We conducted an open-label, randomised, controlled crossover trial to test HAL at nine hospitals between March 6, 2013 a